Russell Investments Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.88M | Buy |
145,240
+10,623
| +8% | +$430K | 0.01% | 1109 |
|
2025
Q1 | $6.92M | Buy |
134,617
+132,450
| +6,112% | +$6.8M | 0.01% | 991 |
|
2024
Q4 | $120K | Buy |
2,167
+56
| +3% | +$3.1K | ﹤0.01% | 2653 |
|
2024
Q3 | $69.4K | Sell |
2,111
-73,765
| -97% | -$2.43M | ﹤0.01% | 2723 |
|
2024
Q2 | $2.06M | Buy |
75,876
+45,840
| +153% | +$1.25M | ﹤0.01% | 1623 |
|
2024
Q1 | $1.09M | Buy |
30,036
+29,959
| +38,908% | +$1.09M | ﹤0.01% | 1944 |
|
2023
Q4 | $1.56K | Buy |
77
+52
| +208% | +$1.05K | ﹤0.01% | 3026 |
|
2023
Q3 | $444 | Hold |
25
| – | – | ﹤0.01% | 3417 |
|
2023
Q2 | $452 | Hold |
25
| – | – | ﹤0.01% | 3367 |
|
2023
Q1 | $314 | Buy |
+25
| New | +$314 | ﹤0.01% | 3223 |
|